2003
DOI: 10.1046/j.1365-2958.2003.03284.x
|View full text |Cite
|
Sign up to set email alerts
|

Lithium and valproate decrease the membrane phosphatidylinositol/phosphatidylcholine ratio

Abstract: . We report here that both drugs decrease the relative rate of membrane phosphatidylinositol synthesis and, to a lesser but still significant degree, the steady state relative phosphatidylinositol composition. In addition, both drugs increase the rate of phosphatidylcholine (PC) synthesis. Finally, valproate, but not lithium, increases expression of phosphatidylcholine pathway genes CHO1 and OPI3 . The overall effect on membrane phospholipid composition is a reduction in the phosphatidylinositol/ phosphatidylc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
15
0

Year Published

2004
2004
2013
2013

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 48 publications
2
15
0
Order By: Relevance
“…While these data suggest that Crg1 may be regulated via the CWI pathway and is transcriptionally responsive to numerous cell wall stressing agents (Figure S9B), we did not detect any drastic fitness defects when crg1 mutants were grown in the presence of cell wall perturbing agents (Figure S9B). However, overexpression of CRG1 in the crg1Δ/Δ mutant did confer resistance to lithium chloride and fenpropimorph, both of which are known perturbants of the cell membrane and other lipid processes (Figure S9C) [53][58]. Together these results supports a model in which Crg1 is involved in lipid-related processes that indirectly impinges on cell wall integrity.…”
Section: Resultssupporting
confidence: 58%
“…While these data suggest that Crg1 may be regulated via the CWI pathway and is transcriptionally responsive to numerous cell wall stressing agents (Figure S9B), we did not detect any drastic fitness defects when crg1 mutants were grown in the presence of cell wall perturbing agents (Figure S9B). However, overexpression of CRG1 in the crg1Δ/Δ mutant did confer resistance to lithium chloride and fenpropimorph, both of which are known perturbants of the cell membrane and other lipid processes (Figure S9C) [53][58]. Together these results supports a model in which Crg1 is involved in lipid-related processes that indirectly impinges on cell wall integrity.…”
Section: Resultssupporting
confidence: 58%
“…This is of interest because PtdIns is a key modulator in several signaling cascades (59) and is a candidate therapeutic target for drugs used to treat bipolar disorder, a disorder that where EPA may be efficacious (6064). Therefore, an interesting aspect of this study was to examine if EPA in PtdIns would increase upon MEP treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Both drugs cause a decrease in intracellular myo-inositol and an increase in expression of INO1 as well as the regulatory gene INO2 required for inositol biosynthesis (20). In addition, both drugs lead to a decrease in the phosphatidylinositol/phosphatidylcholine ratio (38). Furthermore, VPA abrogates the normal response to inositol depletion of inositol-responsive genes and leads to aberrant synthesis of phospholipids (39).…”
mentioning
confidence: 99%